Convatec launches $300m buyback, shares surge

20th Aug 2025 09:03

(Sharecast News) - Convatec surged on Wednesday as the medical products company launched a share buyback programme of up to $300m.

Read more

Director dealings: Convatec CEO sells shares

8th Aug 2025 14:50

(Sharecast News) - Convatec revealed on Friday that chief executive Karim Bitar had disposed of 1.25m ordinary shares in the FTSE 100-listed medical products and technologies company.

Read more

London close: Stocks rise on back of motor lender ruling

4th Aug 2025 17:35

(Sharecast News) - London stocks closed higher on Monday, led by sharp gains among lenders following a favourable Supreme Court ruling on motor finance commissions.

Read more

ConvaTec posts solid first-half revenue, earnings per share growth

29th Jul 2025 08:06

(Sharecast News) - ConvaTec Group posted a solid set of interim results for the first half on Tuesday, reporting broad-based revenue growth, margin expansion, and double-digit growth in earnings per share (EPS).

Read more

London close: Stocks fall after rise in UK consumer inflation

16th Jul 2025 17:49

(Sharecast News) - London equities slipped on Wednesday as stronger-than-expected UK inflation data offset a decline in US producer inflation, prompting investor caution over the interest rate outlook.

Read more

Convatec slides as US CMS proposes to cut spending on skin-substitute products

15th Jul 2025 08:19

(Sharecast News) - Convatec shares fell sharply on Tuesday after the Centers for Medicare & Medicaid Services in the US suggested to cut spending on skin-substitute products, citing "abusive pricing practices".

Read more

Berenberg raises target price on Convatec

27th Jun 2025 09:32

(Sharecast News) - Analysts at Berenberg raised their target price on medical device firm Convatec Group from 310.0p to 335.0p on Friday as it pointed to "good momentum" ahead of the company's interim results.

Read more

London close: Stocks finish lower amid Middle East jitters

23rd Jun 2025 17:44

(Sharecast News) - London stocks ended slightly lower on Monday following a day of choppy trading, as investors took a cautious stance ahead of Iran's expected response to weekend US strikes on its nuclear facilities.

Read more

Convatec hails 'strong' start to 2025

22nd May 2025 07:49

(Sharecast News) - Convatec hailed a "strong" start to 2025 and revising its full-year guidance for top-line growth a tad higher.

Read more

London close: Stocks rise on Trump tariff exemption hopes

14th Apr 2025 15:50

(Sharecast News) - London stocks rallied on Monday, with both the FTSE 100 and FTSE 250 posting strong gains as investors responded to shifting signals on US trade policy.

Read more

Convatec hikes InnovaMatrix sales guidance by 50%

14th Apr 2025 07:14

(Sharecast News) - Medical products group Convatec has said the sales outlook for InnovaMatrix has improved after an announcement by the US government late last week.

Read more

London close: Stocks rise as investors look to Nvidia earnings

26th Feb 2025 15:04

(Sharecast News) - London stocks ended higher on Wednesday, with investors maintaining a cautious yet positive stance ahead of Nvidia's earnings release in the United States later in the global day.

Read more

ConvaTec posts strong results on broad-based chronic care growth

26th Feb 2025 08:42

(Sharecast News) - ConvaTec shares were rising on Wednesday morning after it reported a strong set of financial results for 2024, with revenue rising 6.9% to $2.29bn, supported by broad-based growth across its chronic care categories.

Read more

Convatec disappointed as InnovaMatrix excluded from Medicare coverage

15th Nov 2024 08:04

(Sharecast News) - Medical products group Convatec has expressed disappointment with a ruling which excludes its InnovaMatrix product from Medicare coverage in the US, but says it is confident of securing coverage in the future.

Read more

London close: Stocks rise as dip buyers enter the fray

14th Nov 2024 15:50

(Sharecast News) - London markets ended Thursday in positive territory, with sentiment buoyed by robust corporate updates, as investors digested the latest producer price data out of the United States.

Read more